YHN SPORE collaborators at FCCC have received a five-year, $13.3 million competitive grant renewal from the National Cancer Institute (NCI), part of the National Institutes of Health, to address cancer health disparities.
- July 31, 2023
Researchers have identified a novel subclass of HPV+ head and neck squamous cell carcinoma and demonstrated that treatment could be tailored by tumor type.
- May 02, 2023Source: OncLive
Barbara Burtness, MD, discusses preclinical data on the combination of VIC1911 and adavosertib in head and neck squamous cell carcinoma (HNSCC) and lung cancer.
- January 10, 2023
Aarti Bhatia, MD, MPH, Associate Professor of Medicine (Medical Oncology), has been named Leader of the Head & Neck Disease-Aligned Research Team (DART) for Yale Cancer Center and Smilow Cancer Hospital.
- December 01, 2022
Barbara Burtness, MD, Named Chief Translational Research Officer for Yale Cancer Center and Smilow Cancer Hospital
Barbara Burtness, MD, Professor of Medicine (Medical Oncology), has been named Chief Translational Research Officer for Yale Cancer Center and Smilow Cancer Hospital and Associate Cancer Center Director for Translational Research for Yale Cancer Center.
- June 22, 2022
Comprehensive Viral Genotyping Reveals Prognostic Viral Phylogenetic Groups in HPV16-Associated Squamous Cell Carcinoma of the OropharynxSource: AACR
Comprehensive Viral Genotyping for Head and Neck Cancers.
- May 26, 2022Source: Oncotarget
Researchers developed a new tool aimed at better classifying HPV+ HNSCC patients with good or poor prognosis in an effort to personalize treatment and improve patient outcomes.
- May 14, 2022Source: National Library of Medicine
Oropharyngeal squamous cell carcinoma (OPSCC) accounts for over half of all head and neck cancers. Since the 1970s, OPSCC has shifted from an environmentally triggered to virally mediated disease due to a sharp rise in human papillomavirus (HPV)-related SCC.
- May 03, 2022
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as Connecticut Magazine 'Best Doctors'
Connecticut Magazine has named 87 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2022 Best Doctors guide.
- April 06, 2022Source: AACR Journals
Head and neck squamous cell carcinoma (HNSCC) is a frequently devastating cancer that affects more than a half million people annually worldwide. In a paper recently published in AACR Journals, Dr. Barbara Burtness reveals the relation of the interaction of TP53 and CDKN2A mutations with elevated tumor mutation burden in HNSCC.